This InspectorProfile is a report of relevant audit-related information on Daniel Lahar, a U.S. Food & Drug Administration investigator who primarily conducts inspections in the area of Medical Devices & Rad Health.
This InspectorProfile report is updated through and lists Daniel Lahar's 420 inspections in 18 countries: Switzerland, Germany, Lithuania, United States, Netherlands, France, Italy, Sweden, United Kingdom, India, Australia, Costa Rica, Brazil, China, Korea (the Republic of), Taiwan, Thailand, and Japan.
FDA audits are stressful. Whether you are issued a 483 depends largely on your compliance with GxP and predicate rules; but it can also depend on the Agency's current focus and the tendencies of your specific investigator(s). FDAzilla has curated Daniel Lahar's inspection information so that you can mitigate investigator-related risks.
Below is an example of what a FDAzilla InspectorProfile report contains; This is not the actual data for Daniel Lahar.
Note: The EIR and 483 documents are sold separately.Add To Cart38 of Daniel's 483s Available Now.